The EU Commission invites parties to submit comments regarding a pharma company and its excessive pricing (Aspen)

On 14 July 2020, the Commission invited interested parties to submit comments on the commitments offered by global pharma company Aspen to address competition concerns in relation to Aspen’s excessive pricing for six critical off-patent cancer medicines in several

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Eugenia Caracciolo-Drudis, The EU Commission invites parties to submit comments regarding a pharma company and its excessive pricing (Aspen), 14 July 2020, e-Competitions July 2020, Art. N° 96290

Visites 82

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues